Promoting Excellence in Education, Research,
and Patient Care in the Rapidly Evolving
Management of Gastrointestinal Cancer
International Society of
Gastrointestinal Oncology
isgioEstablished 2003

2018 Conference Slides

Session 1: Pancreatic Cancer
Chairperson: Michael Choti, MD
  Role for Local/Regional Therapy in Advanced Disease
  Case 1: Borderline PDAC with Arterial Abutment
Mekhail Anwar, MD (Mentor); Matthew Susko, MD (Fellow)

  Case 3: Case of Advanced PDAC, Progression and Carcinomatosis Beyond First Line Therapy
Davendra Sohal, MD (Mentor); Meena Sadaps, MD (Fellow)

Session 2: Hepatobiliary Cancer
Chairpersons: Michael Choti, MD; Ghassan Abou-Alfa, MD
  Managing Incidental Gallbladder Cancer
Shishir K. Maithel, MD

  Adjuvant Therapy for Cholangiocarcinoma: Chemoradiation is Best
Edgar Ben-Josef, MD
  Case 3: Multidisciplinary Management of Distal Cholangiocarcinoma
Michael Choti, MD (Mentor); Atuhani Burnett, MD (Fellow)

Session 3: Esophageal/Gastric Cancer
Chairpersons: Weijing Sun, MD; Nataliya Uboha, MD
  Preoperative CROSS is the Preferred Treatment for Locally Advanced GEJ
Nataliya Uboha, MD
  Current Status and Future Directions of Targeted Agents and Immunotherapy in Gastric Cancer
Yung-Jue Bang, MD

  Genomic Profiling and Biomarker Guided Therapy in Esophagogastric Cancer
Samuel Klempner, MD

  Proffered Paper
TAGS: A Phase 3, Randomized, Double-Blind Study of Trifluridine/Tipiracil (TAS-102) vs Placebo in Patients with Refractory Metastatic Gastric Cancer
Ben George, MD
Friday, November 2, 2018
Session 4: Hot Topics in Gastrointestinal Oncology
Chairpersons: Axel Grothey, MD, Howard Hochster, MD
  Immuno-oncology - Beyond PD1 Single Agent
Michael Overman, MD

  Cellular Therapies:  Wishful Thinking in GI Cancer?
Jaffer Ajani, MD

  Tumor Mutation Profiling in GI Cancer - Worthwhile or Not?
Howard Hochster, MD
  ESMO Update
Axel Grothey, MD

Session 5: Localized/Adjuvant Colorectal Cancer
Chairpersons: Daniel Haller, MD
  Duration of Adjuvant Therapy for Colon Cancer
Anthony Shields, MD
  Q & A (5 minutes)
  Non-Operative Management of Rectal Cancer
Najjia Mahmoud, MD
Session 6: Neuroendocrine Tumors (NET)
Chairperson: Jonathan Strosberg, MD
  Endoscopic and Surgical Management of Gastric and Duodenal NETs
Sebastian Maasberg, MD

  High Grade Neuroendocrine Cancers: Should They all be Treated Similarly?
Thor Halfdanarson, MD

  Case 1: Discussion of Treatment Options for NET Progressing on a First-line Somatostatin Analog
Jonathan Strosberg, MD (Mentor); Amr Mohammed, MD (Fellow)

Session 7: Advanced Colon Cancer
Chairpersons: Axel Grothey, MD; Al Benson, MD
  How to Treat mCRC? Making Sense of all the Data
Axel Grothey, MD

  BRAF Mutated mCRC – Specific Considerations for Treatment
Dustin Deming, MD
  Immunotherapy of Anal Cancer
Cathey Eng, MD